Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Outcome of dialysis-requiring acute kidney injury in patients with infective endocarditis: A nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of neurological disorders in patients with European Lyme neuroborreliosis. A nationwide population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • European HIV Continuum of Care Working Group
  • Niels Obel (Member of study group)
View graph of relations

BACKGROUND: High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region.

METHODS: A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed who ever initiated ART; and proportion of those ever treated who achieved viral suppression at their last visit.

RESULTS: We estimated that 87% of PLHIV were diagnosed; 92% of those diagnosed had ever initiated ART; and 91% of those ever on ART, or 73% of all PLHIV, were virally suppressed. Corresponding figures for men having sex with men were: 86%, 93%, 93%, 74%; for people who inject drugs: 94%, 88%, 85%, 70%; and for heterosexuals: 86%, 92%, 91%, 72%. The proportion suppressed of all PLHIV ranged from 59% to 86% across countries.

CONCLUSIONS: The EU is close to the 90-90-90 target and achieved the UNAIDS target of 73% of all PLHIV virally suppressed, significant progress since 2013 when 60% of all PLHIV were virally suppressed. Strengthening of testing programs and treatment support, along with prevention interventions, are needed to achieve HIV epidemic control.

Original languageEnglish
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume71
Issue number11
Pages (from-to)2905-2916
Number of pages12
ISSN1058-4838
DOIs
Publication statusPublished - 31 Dec 2020

ID: 62273282